Adcendo Benefits From ADC Excitement To Raise More Cash
Preclinical Biotech Brought In Over €80m
The Danish start-up intends to use the proceeds from a €31m series A extension financing to initiate a broad clinical program for its uPARAP antibody-drug conjugate in sarcoma.
